Recent Articles from Investor Brand Network

A new report from congressional researchers is shedding light on what the Trump administration’s move to reclassify cannabis could mean for the industry, while also outlining the limits of the policy shift under federal law.

Pershing Square USA (NYSE: PSUS) and Pershing Square Inc. (NYSE: PS) announced the closing of their combined initial public offerings and previously announced combined private placement, generating gross proceeds of $5 billion for PSUS before deducting sales loads, placement fees and offering expenses. The PSUS shares and PSI shares began trading on the New York Stock Exchange on April 29, 2026, under the symbols PSUS and PS, respectively.

Delta Gold Technologies (Aquis: DGQ /OTC:DGQTF) is featured in the debut episode of The Innovation Report Series, a new documentary initiative exploring technologies, industries and companies shaping the future global economy. The first episode, The Quantum Revolution , examines the advancing commercial potential of quantum technologies and their potential impact across industries, while the broader series explores the intersection of innovation, capital markets and industrial transformation. The upcoming second episode will focus on the critical minerals sector and feature Guardian Metal Resources (LSE: GMET) (NYSE American: GMTL) (OTC: GMTLF).

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.

The copper market has remained on edge as geopolitical risks stoke volatility . As a result, prices have swung widely in response to news headlines. According to an analysis published by ING, the current market behavior is driven more by political news rather than the usual market fundamentals.

Cannabis rescheduling in the U.S. could reshape scientific research and parts of the industry, though key questions remain about how the change will be carried out.

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.

Twin Vee PowerCats (NASDAQ: VEEE) reported first-quarter 2026 revenue growth of approximately 10% year over year and 31% sequentially, marking its fourth consecutive quarter of year-over-year revenue gains, as the company continued expanding its product lineup with the relaunch of Bahama Boat Works. Twin Vee posted a net loss of $2.09 million, compared with $1.6 million in the prior-year quarter, while adjusted EBITDA loss improved 11% to $776,000. The company said results included approximately $1.3 million in non-cash and one-time items tied to inventory adjustments, product development and field inventory management, while cash and equivalents increased by more than $4 million from the fourth quarter.

Datavault AI (NASDAQ: DVLT) highlighted the strategic positioning of its distributed edge computing network ahead of this week’s anticipated U.S. Senate Banking Committee markup of the Digital Asset Market Clarity Act, legislation aimed at establishing a comprehensive federal framework for digital assets. The company said it expects regulatory clarity to support increased demand for secure data processing, tokenization and AI infrastructure, as it advances deployment of a modular mini data center network targeting more than 100 U.S. metropolitan markets with full commercial availability of a planned 48,000-GPU fleet beginning in the third quarter of 2026.

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG patch in approximately 50 patients with suspected coronary artery disease at two hospitals in Belgrade, Serbia. The study will compare synthesized 12-lead ECG readings generated by the company’s patch immediately following exercise stress testing against standard 12-lead ECGs, supporting HeartBeam’s regulatory strategy for a device designed to expand ambulatory cardiac monitoring beyond rhythm assessment into ischemia detection within an established approximately $2 billion patch-based monitoring market.

In clinical-stage biotechnology, the central challenge is rarely scientific discovery. It is capital. Advancing multiple therapeutic candidates through preclinical work, clinical trials, and regulatory approval requires sustained funding, and traditional financing routes often come at the cost of dilution or loss of asset control. With biotech capital markets remaining selective and the IPO window constrained, alternative models that preserve shareholder value while advancing pipelines are gaining traction.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

A systematic review in JAMA Network Open suggests earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes in patients being treated for late-stage solid tumors . The analysis pooled data from 29 studies encompassing more than 6,000 patients. Earlier timing was linked to gains in both survival endpoints, though prospective validation is required before scheduling adjustments can be broadly adopted.

Apple has agreed to pay a $250 million settlement in the United States to resolve a lawsuit over its artificial intelligence marketing for recent iPhones. The case focused on claims that the company misled customers about the capabilities and availability of new AI features promoted under the name Apple Intelligence.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to healthcare and public health management. Traditional methods such as breathalyzers, blood tests and urine screenings are often limited by their invasiveness, delayed results or inability to assess real-time impairment, particularly in cases involving multiple substances. As patterns of substance use evolve and the societal costs of impaired behavior continue to rise, the demand for faster, more scalable and noninvasive diagnostic solutions is becoming increasingly urgent. MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) ( Profile ) is advancing a novel approach that leverages artificial intelligence (“AI”) and voice analysis to predict intoxication from short speech samples. By focusing on the human voice as a measurable indicator of internal physiological and cognitive states, the company is working to develop a platform capable of detecting impairment across a range of substances in real-time. This approach not only addresses a critical gap in existing detection methods but also reflects a broader shift toward AI-driven, noninvasive diagnostics with the potential to transform regulatory enforcement, workplace safety and public health outcomes. MindBio joins other key companies operating at the forefront of health, AI and diagnostics technologies, including HeartFlow Inc. (NASDAQ: HTFL), Recursion Pharmaceuticals Inc. (NASDAQ: RXRX), Tempus AI Inc. (NASDAQ: TEM) and…

BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this challenge is the blood-brain barrier (BBB), a biological defense system that prevents most therapeutics from reaching the central nervous system (“CNS”). As Alzheimer’s disease cases rise globally and governments intensify focus on biodefense preparedness, the inability to deliver drugs effectively to the brain is emerging as a critical bottleneck in modern medicine. With this in mind, innovative companies, including Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), are working within a broader industry shift toward advanced delivery platforms designed to bypass traditional barriers and facilitate rapid, targeted access to the brain. Oncotelic’s approach, which includes a proprietary intranasal nose-to-brain (“N2B”) system that enables rapid therapeutic delivery, reflects a growing recognition that solving CNS delivery, not just drug discovery, may be key to unlocking the next generation of therapies. Oncotelic joins a group of leading biopharma companies focused on cutting-edge therapeutic platforms and large-scale drug development in a range of treatment areas, including Biogen Inc. (NASDAQ: BIIB), Moderna Inc. (NASDAQ: MRNA), CytoDyn Inc. (OTCQB: CYDY) and…

AINewsWire Editorial Coverage : The nature of modern warfare is being rewritten in real time, driven by the rapid rise of cheap, mass-produced drones that are reshaping the economics of conflict. In war zones such as Ukraine, millions of low-cost systems, often built in small workshops or adapted from commercial designs, are now performing missions once reserved for advanced aircraft and precision-guided weapons. But while the hardware has become abundant and accessible, a critical limitation has emerged: Most of these drones lack the intelligence to operate independently in contested environments. GPS jamming, electronic warfare and the need for constant human control expose a growing gap between what drones can do and what they need to do to remain effective at scale. Increasingly, defense leaders recognize that the next phase of this revolution will not be defined by better hardware but by better software: the intelligence layer that enables autonomy, navigation, and precision without relying on vulnerable systems. SPARC AI Inc. (OTC: SPAIF) ( Profile ) is positioning itself directly within this shift, developing a software-only platform designed to give any drone, regardless of cost or manufacturer, the ability to operate with GPS-denied navigation and precision targeting. SPARC AI is one of several companies working in the drone, AI and defense-tech space, including leaders such as Swarmer Inc. (NASDAQ: SWMR), Unusual Machines (NYSE American: UMAC), Draganfly Inc. (NASDAQ: DPRO) and…

BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (“T2DM”) have become two of the most pressing healthcare challenges worldwide, driving rising rates of cardiovascular disease, fatty liver disease, kidney complications and escalating healthcare costs. What began as a niche class of diabetes medications has evolved into one of the most transformative therapeutic categories in modern medicine, with GLP-1 receptor agonists now reshaping obesity treatment, metabolic care and potentially even neurodegenerative disease management. Against this backdrop, SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF), ( Profile ) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history. SureNano is one of the emerging microcap companies operating in the GLP space, forming part of a group of companies leading the way in the GLP-1 space, including Eli Lilly and Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Amgen Inc. (NASDAQ: AMGN) and…

Oncotelic Therapeutics (OTCQB: OTLC) is positioning itself within a growing push to overcome one of modern medicine’s most persistent challenges: delivering therapeutics effectively across the blood-brain barrier. Through its proprietary intranasal nose-to-brain delivery platform, the company is pursuing targeted central nervous system applications spanning Alzheimer’s disease and biodefense, reflecting broader industry recognition that delivery technology may be as critical as drug discovery itself. Oncotelic is part of an innovative therapeutic landscape that includes Biogen Inc. (NASDAQ: BIIB), Moderna Inc. (NASDAQ: MRNA), CytoDyn Inc. (OTCQB: CYDY) and Northwest Biotherapeutics Inc. (OTCQB: NWBO).

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

NanoViricides, Inc. (NYSE American: NNVC) highlighted the potential need for broad-spectrum antiviral treatments following the recent Andes hantavirus incident aboard a cruise ship, pointing to its clinical-stage antiviral candidate NV-387 as a potential therapeutic platform for emerging viral threats. The company said NV-387 has completed a Phase I safety and tolerability trial in healthy volunteers and has demonstrated effectiveness in animal models involving multiple viral lung infections, including coronaviruses, RSV, influenza, monkeypox and measles, as it advances development of a platform designed to target a broad range of pathogenic viral infections.

Safe Pro Group (NASDAQ: SPAI) announced it has been invited to train and equip soldiers with its patented SPOTD Edge AI battlefield threat detection system during a U.S. Army Force-on-Force combat training exercise scheduled for the second quarter of 2026. The exercise, one of the Army’s most realistic combat training environments, will allow Safe Pro to demonstrate rapid AI-powered explosive threat identification and enhanced battlefield mapping capabilities in simulated live combat conditions.

Kairos Pharma (NYSE American: KAPA) announced that its annual meeting of shareholders will be held virtually at 9 a.m. PDT on June 29, 2026, with meeting materials to be mailed following finalization and filing with the SEC. The clinical-stage biopharmaceutical company also disclosed that its 2025 annual report included an audit report containing a going concern explanatory paragraph from its independent registered public accounting firm, as required under Section 610(b) of the NYSE American Company Guide, noting the disclosure does not reflect any change or amendment to previously filed financial statements.

Lavish Enterprises (OTC: VXIT) announced it has executed a definitive agreement to acquire exclusive, perpetual and irrevocable commercial rights to FleetPath, an AI-native operating system designed to unify freight lifecycle operations for trucking carriers, brokers, shippers and drivers within a single platform. The company said FleetPath is operational and approaching beta-stage deployment, with initial customer rollouts targeted as the platform enters beta, as Lavish looks to address inefficiencies across the fragmented trucking software market.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Yahoo Finance’s Hal Bundrick explores how crypto-backed mortgages may signal a broader transformation in home financing and tokenized asset lending

Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics division, announced a strategic partnership initiative with ToDo Robotics aimed at accelerating the expansion of its AI-powered automation and Robotics-as-a-Service platform across U.S. commercial markets. ToDo Robotics, which has completed more than 300 robotic system deployments, is expected to contribute deployment infrastructure, customer relationships and operational support, while TechForce plans to provide robotic delivery systems, hospitality automation platforms, AI-enhanced technologies and software integration capabilities.

Greenland Energy (NASDAQ: GLND) is positioning itself within a shifting global energy landscape, as policymakers and industry leaders increasingly look beyond traditional oil-producing regions in search of new, scalable hydrocarbon resources. Years of underinvestment in upstream development, combined with reserve depletion in mature basins and rising geopolitical instability, are driving renewed interest in frontier exploration .

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

A recent federal decision to reclassify medical cannabis is reshaping the outlook for licensed operators, prompting renewed attention from businesses and regulators across the country.

Frontieras is positioned amid increased demand for domesticenergy production. “At the core of its strategy is Frontieras’s FASForm(TM) process, which the company describes as a solid carbon fractionation technology that separates coal into its constituent components,” reads a recent article.

Greenland Energy (NASDAQ: GLND) is an exploration-focused oil and gas company targeting development in the Jameson Land Basin, a large and historically underexplored hydrocarbon region in the Arctic. Formed through the completed business combination of Pelican Acquisition Corporation, Greenland Exploration Limited, and March GL Company, “the company’s vision is to responsibly unlock Greenland’s energy potential, supporting both local development and global energy security through science-driven exploration and innovation,” reads a recent article. “The company is working to progress exploration across the Jameson Land Basin, which has been studied extensively but remains undrilled, combining historical geological work with modern seismic analysis and planned drilling programs. Its efforts are focused on unlocking the hydrocarbon potential identified through decades of prior research while progressing toward initial well development.”

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

This article has been disseminated on behalf of Blue Moon Metals Inc. and may include paid advertising.

Newsmax (NYSE: NMAX) announced that it has surpassed 25 million followers across its social media platforms, reaching 25.4 million total followers as the company continues expanding its digital audience. The milestone comes alongside record audience metrics, including 104.18 million Facebook user reach in the first quarter of 2026, up 44% sequentially and 119% year over year, while the Newsmax App has exceeded 13 million downloads as the company broadens its multi-platform media presence.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Strawberry Fields REIT (NYSE AMERICAN: STRW) reported first-quarter 2026 results showing growth in key operating metrics, with FFO rising to $20.9 million, or $0.38 per share, from $18.3 million, or $0.33 per share, in the prior-year quarter, while AFFO increased to $18.8 million, or $0.34 per share, from $16.8 million, or $0.30 per share. Net income rose to $9.5 million from $7.0 million, rental income increased to $40.0 million from $37.3 million, and the company collected 100% of contractual rents while also signing a term sheet for a $300 million corporate credit facility expected to close in the second quarter to refinance debt and support acquisition growth.

Nightfood Holdings (OTCQB: NGTF) is featured in a NetworkNewsAudio Audio Press Release titled “Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion,” which highlights accelerating adoption across the service robotics sector as advances in artificial intelligence, machine vision and sensor integration drive the shift from conceptual development to real-world deployment. The editorial spotlights Nightfood’s TechForce Robotics unit and its focus on practical hospitality automation solutions designed to deliver immediate operational value as service robotics adoption scales.

Strawberry Fields REIT (NYSE AMERICAN: STRW) announced that its board of directors has declared a quarterly cash dividend of $0.17 per common share. The dividend will be paid on June 30, 2026, to stockholders of record at the close of business on June 16, 2026.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is expanding beyond its core energy initiatives with the launch of a Government Procurement Services operating segment. The move reflects an effort to diversify operational activities while building relationships within defense and institutional procurement channels.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Following January’s surge to record highs, copper prices have entered a more cautious phase, reacting closely to developments surrounding the Iran crisis. The ongoing closure of the Strait of Hormuz presents a paradox for the market, creating both upward and downward pressure on prices.

Norway recorded a 98.6% EV share of new passenger car registrations in April, breaking the prior record of 98.4% set just one month earlier. Of April’s 11,103 registrations, 10,952 were fully electric, while just 87 were diesel and 31 petrol, according to the OFV, Norway’s Road Federation .

Last week, the U.S. Department of Justice announced a plan to tackle tech-driven fraud in the health care system on the West Coast . The initiative will focus on California, Arizona and Nevada. Their investigations will target fraudulent schemes, especially those executed by digital health firms.

A research team at Mayo Clinic has developed an artificial intelligence system that can spot warning signs of pancreatic cancer 3 years before a formal diagnosis is made. The findings, published this week in the journal Gut, suggest the technology could help doctors identify the disease far earlier than is currently possible.

A U.S.-Israeli military strike on Iran in late February has sent oil and gas prices climbing worldwide. Energy companies posted sharply higher earnings in the first quarter of 2026, and analysts expect the windfall to continue. Advocacy groups are renewing calls for governments to tax the gains and direct the revenue toward clean energy and household relief .

Russia’s leading regulated trading platform is drawing attention after announcing plans tied to Ripple’s XRP token. The Moscow Exchange (MOEX) has revealed it will introduce an official index tracking XRP prices, part of a broader effort to expand its footprint in crypto.

Advances in AI have created new opportunities for health care wearables to be leveraged as tools to provide clinicians with meaningful insights that they can act upon . The previous generation of wearables merely generated immense streams of data that needed to first be analyzed before actionable insights could be obtained. This is now changing.

Crypto firms are urging U.S. lawmakers to move forward after Senators reached a compromise on new stablecoin rules. The agreement comes after months of debate between banks and the crypto industry over how digital dollar tokens should be regulated. Industry leaders say the compromise is a step forward and want Congress to act quickly so the bill can move through the Senate Banking Committee without delay.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

KALA BIO (NASDAQ: KALA) implemented a 1-for-50 reverse stock split of its common stock, effective at 4:05 p.m. on May 8, 2026, with split-adjusted trading set to begin on the Nasdaq Capital Market at the open on May 11, 2026. The reverse split will reduce the company’s outstanding common shares from approximately 929.5 million to 18.6 million, with cash payments issued in lieu of fractional shares and proportional adjustments made to outstanding equity awards, warrants and other convertible securities.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled security, defense, and situational awareness solutions, recently entered into a Master Teaming with a U.S. Government prime defense contractor to deliver AI-powered air and ground solutions to support the U.S. Government ( https://ibn.fm/0OJeW ).

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

American Fusion (OTC: AMFN) reported that fabrication partners in Odessa, Texas, have completed the structural frame for the company’s 5MW Texatron(TM) pre-production unit, marking a key engineering milestone as the fusion energy developer moves from prototype development toward integrated system assembly and controlled testing. The unit is undergoing additional integration work before shipment to American Fusion’s Fort Worth facility, where the company plans to begin system testing, diagnostics validation and safety evaluations following regulatory review and site readiness preparations.

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.

This article has been disseminated on behalf of Cizzle Brands Corporation and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

SKYX Platforms (NASDAQ: SKYX), a smart home and AI platform technology company, announced it will host a corporate update conference call on May 11, 2026, at 4:30 p.m. Eastern Time to discuss new developments, provide a first-quarter 2026 business overview and review financial results, with participation from Founder and Executive Chairman Rani Kohen, CEO Lenny Sokolow, President Steve Schmidt and CFO Marc Boisseau.

Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, unveiled the next phase of development for its withZeta.ai platform, including planned launches of ZetaSwarm(TM), an autonomous multi-agent AI research system, ZetaOmics(TM), a computational biology and multi-omic analytics toolkit, and new enterprise-grade capabilities designed to support institutional oncology research and drug discovery workflows.

The biotechnology sector is undergoing a meaningful shift in how companies are evaluated, challenging long-standing assumptions about value creation. Traditionally, valuation has been closely tied to revenue generation and near-term financial performance. However, this framework has never fully captured the realities of biotech, where long development timelines, regulatory complexity, and scientific uncertainty often delay commercialization for years.

Oragenics (NYSE American: OGEN) and Sigyn Therapeutics Inc. (OTCQB: SIGY) announced the signing of a letter of intent under which Oragenics expects to obtain an exclusive license to develop and commercialize Sigyn’s CardioDialysis(TM) blood purification technology for traumatic brain injury and chronic neurodegenerative diseases, complementing Oragenics’ Phase IIa intranasal neurosteroid candidate ONP-002 in a proposed dual-modality approach targeting inflammation on both sides of the blood-brain barrier.

Datavault AI (NASDAQ: DVLT) announced that management has begun evaluating a potential dividend spin-out of its Acoustic Sciences division into a standalone public company proposed to be named API Media, with the reserved Nasdaq ticker symbol “ADIO,” as the company seeks to separate its acoustic technologies and live events operations from its AI-driven data monetization business. The proposed transaction remains subject to board approval, definitive agreements, regulatory approvals and other closing conditions.

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire examining the accelerating adoption of service robotics across industries including healthcare, logistics and hospitality, highlighting the company’s focus on scalable AI-driven robotics systems and strategic collaborations as global demand for automation continues to expand.

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, announced a strategic initiative to explore ibogaine-based therapeutics for traumatic brain injury and related neuropsychiatric conditions, including the filing of a provisional U.S. patent application covering compositions and methods using ibogaine and related compounds to treat TBI, PTSD and associated disorders.

NextPlat (NASDAQ: NXPL, NXPLW) a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced that it will release its financial results for the first quarter ended March 31, 2026, on May 14, 2026.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding the company’s launch footprint into Southern California and completing its initial targeted markets alongside New York metro, Dallas and South Florida as it advances commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology.

A recent study highlights how careful planning of wind farm locations across Europe can help preserve visually appealing landscapes without significantly raising electricity generation costs. While this finding is encouraging at a continental scale, challenges still arise at regional levels where the goals of renewable energy expansion and landscape conservation often overlap.

Used electric vehicle sales are climbing sharply as prices close in on those of comparable gas-powered models. In March, used EV sales were 27.7% higher than the same month a year prior and 53.9% above February’s total, according to the Cox Automotive EV Monitor . A key factor behind the supply surge is the volume of vehicles leased between late 2022 and the end of 2023. Most of those agreements run three years, and the cars are now flowing back onto dealer lots in large numbers.